retatrutide phase 2 study results Looking forward to when #retatrutide's 3 trial will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Retatrutide Shows Promising Results in

Save Eli Lilly released top-line data from TRIUMPH-1 on May 21, 2026 the pivotal Phase 3 obesity trial that will anchor retatrutide's New Drug Application

Pitt B, Pfeffer MA, Assmann SF, et al

It doesnt take much these days to fall down a GLP-1 rabbit hole on the internet

173 The findings from this study further support ghrelins ability to mediate insulinostatic actions, and that reduction in plasma ghrelin could either promote T2D pathogenesis or be an adaptive response to stop further reduction in insulin secretion in T2D patients

Your doctor will determine the best treatment plan based on your weight loss goals, medical history, overall health, and individual response to medication.

The BMI formula is weight in kilograms divided by height in meters squared